Itron (NASDAQ:ITRI) Stock Price Target Cut by BNP Paribas Exane

Itron (NASDAQ:ITRI) had its price objective lowered by equities research analysts at BNP Paribas Exane from $115.00 to $105.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the scientific and technical instruments company’s stock. BNP Paribas Exane‘s target price suggests a potential upside of 11.05% from the stock’s current price.

ITRI has been the subject of several other reports. Zacks Research downgraded Itron from a “strong-buy” rating to a “hold” rating in a report on Monday, October 19th. Seaport Research Partners restated a “buy” rating and set a $150.00 price target on shares of Itron in a research note on Wednesday, July 29th. Needham & Company LLC lifted their price target on Itron from $116.00 to $128.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Oppenheimer reaffirmed an “outperform” rating on shares of Itron in a research report on Wednesday. Finally, Weiss Ratings upgraded Itron from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, October 12th. Nine equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $129.60.

Itron Trading Up 7.8%

Shares of NASDAQ:ITRI opened at $94.55 on Wednesday. The company’s fifty day moving average price is $91.26 and its 200 day moving average price is $91.10. Itron has a 12 month low of $77.77 and a 12 month high of $142.00.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Tuesday, October 27th. The scientific and technical instruments company reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.38. The company had revenue of $599.33 million during the quarter, compared to analyst estimates of $595.50 million. The business’s revenue was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.54 EPS. On average, analysts anticipate that Itron will post 6.41 EPS for the current fiscal year.

Insider Buying and Selling

In other Itron news, SVP Donald Reeves, III sold 329 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $98.79, for a total transaction of $32,501.91. Following the completion of the sale, the senior vice president directly owned 27,945 shares of the company’s stock, valued at $2,760,686.55. This represents a 1.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Justin Patrick sold 10,210 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $97.36, for a total value of $994,045.60. Following the sale, the senior vice president directly owned 22,065 shares of the company’s stock, valued at $2,148,248.40. The trade was a 31.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 17,903 shares of company stock worth $1,753,521. Insiders own 1.77% of the company’s stock.

Institutional Investors Weigh In On Itron

Several large investors have recently modified their holdings of the stock. Assenagon Asset Management S.A. raised its holdings in Itron by 160.4% during the second quarter. Assenagon Asset Management S.A. now owns 336,710 shares of the scientific and technical instruments company’s stock worth $29,136,000 after purchasing an additional 207,416 shares in the last quarter. Readystate Asset Management LP purchased a new stake in Itron in the 2nd quarter valued at approximately $1,809,000. Arrowstreet Capital Limited Partnership boosted its holdings in Itron by 12.2% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock valued at $60,359,000 after purchasing an additional 73,020 shares in the last quarter. WCM Investment Management LLC increased its position in Itron by 49.5% during the 1st quarter. WCM Investment Management LLC now owns 87,175 shares of the scientific and technical instruments company’s stock worth $7,312,000 after purchasing an additional 28,857 shares during the period. Finally, John G Ullman & Associates Inc. increased its position in Itron by 37.4% during the 1st quarter. John G Ullman & Associates Inc. now owns 80,656 shares of the scientific and technical instruments company’s stock worth $7,229,000 after purchasing an additional 21,975 shares during the period. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Key Stories Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q3 earnings beat expectations: Itron reported adjusted earnings of $1.94 per share, well above the $1.56 analyst consensus, while revenue of $599.3 million exceeded expectations of $595.5 million. Revenue grew 3% year over year, and earnings increased from $1.54 per share in the prior-year quarter. Itron Third-Quarter Earnings Results
• Positive Sentiment: Recurring revenue and backlog strengthened: Annual recurring revenue rose 25% to $423 million, while total backlog reached $4.3 billion. The company also generated $102 million in operating cash flow and $96 million in free cash flow, supporting the quality of the quarter’s results. Itron Q3 Revenue and Recurring Revenue Report
• Positive Sentiment: Guidance supports the outlook: Itron forecast fourth-quarter revenue of $621 million to $636 million and full-year 2026 revenue of $2.37 billion to $2.385 billion. The strong outlook is reinforcing investor confidence in utility technology and smart-grid demand. Itron Announces Third-Quarter 2026 Financial Results
• Neutral Sentiment: Technical momentum improved: ITRI broke above its 200-day moving average, a potentially bullish technical signal that may attract momentum-focused investors. The stock remains below its 52-week high, however, leaving valuation and follow-through as key considerations. Itron Stock Breaks Above Two-Hundred-Day Moving Average
• Negative Sentiment: Valuation concerns remain: BNP Paribas Exane lowered its price target to $105, signaling more limited upside in the analyst’s view despite the earnings beat. Separately, reported insider activity showed selling by company executives with no purchases during the period, a potential cautionary signal. BNP Paribas Exane Lowers Itron Price Target

Itron Company Profile

Itron, Inc is a technology company that provides solutions to utilities and cities for managing electricity, natural gas, and water resources. Its offerings help organizations measure consumption, collect and analyze data, improve operational efficiency, and support more reliable and sustainable delivery of essential services.

The company’s portfolio includes smart meters, advanced metering infrastructure, communications networks, sensors, data management systems, and utility software.